echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > J Virol: scientists find Ebola or a solid ally against brain tumors

    J Virol: scientists find Ebola or a solid ally against brain tumors

    • Last Update: 2020-02-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    February 20, 2020 / bioun / -- glioblastoma is a kind of intractable, refractory and fatal brain tumor Scientists at Yale University have found the most unlikely ally, part of the Ebola virus, to treat the cancer "Ironically, one of the world's deadliest viruses may be useful in treating one of the deadliest brain cancers," said Anthony van den pol, Professor of Neurosurgery at Yale University This approach takes advantage of the weakness of most cancer tumors and the response of the Ebola virus defense system to pathogens Photo source: unlike normal cells, most cancer cells lack the ability to produce natural immune responses against invaders such as viruses, which led cancer researchers to explore the use of viruses against various cancers There is a clear risk of using viruses - they can cause potentially dangerous infections To solve this problem, scientists including van den pol have tried to create or test chimeric viruses, or gene combinations of multiple viruses They have the ability to target cancer cells without harming the patient One of the seven genes that help the Ebola virus avoid immune system reactions also contributes to its lethality This attracted van den pol's interest He and lead author Xue Zhang, also from Yale University, used a chimeric virus containing the Ebola virus gene, a glycoprotein with a mucin domain (MLD) In wild-type Ebola virus, MLD plays the role of hiding Ebola virus in the immune system They injected the chimeric virus into the brains of glioblastoma mice and found that MLD helped selectively target and kill deadly glioblastoma brain tumors (Note: the team used MLD glycoprotein instead of the full Ebola virus )Van den pol said the beneficial effect of MLD seems to be to protect normal cells from infection, not cancer cells, which lack the ability to produce an immune response to pathogens A key factor, he said, could be that viruses with glycoprotein MLD replicate more slowly, which could make it safer than viruses without glycoprotein MLD In theory, he said, the virus could be used in combination with surgery to eliminate glioblastoma tumors and help prevent cancer recurrence Reference: Xue Zhang et al, mucin like domain of Ebola virus glycoprotein enhancements selective online actions against brain tubes, Journal of Virology (2020) Doi: 10.1128/jvi.01967-19
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.